Bayer stops late-stage Nexavar trial

(Reuters) - Bayer HealthCare, a U.S.-based unit of Bayer AG , stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet the main goal of... 9 months ago